Advanced glycation end-products: a review
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Advanced glycation end-products are a complex and heterogeneous group of compounds that have been implicated in diabetes related complications. At present it is not known if they are the cause or the consequence of the complications observed. We discuss the chemistry of advanced glycated end-product formation and their patho-biochemistry particularly in relation to the diabetic microvascular complications of retinopathy, neuropathy and nephropathy as well as their role in the accelerated vasculopathy observed in diabetes. The concept of carbonyl stress as a cause for advanced glycated end-product toxicity is mentioned. We discuss alterations in the concentrations of advanced glycated end-products in the body, particularly in relation to changes occurring with age, diabetes and its complications such as nephropathy. Problems relating to current methods of advanced glycated end-product detection and measurement are highlighted including the lack of a universally established method of detection or unit of measurement. Agents used for the treatment of advanced glycated end-product accumulation are reviewed, with an emphasis on the results of the recent phase III trials using aminoguanidine and diabetes related complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About 20 various AGEs have been detected in blood and tissues, as well as in foods.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The most abundant non-fluorescence AGEs involve carboxymethyl-lysine (CML), and carboxyethyl-lysine (CEL). Fluorescence AGEs involve methylglyoxal-lysine and pentosidine (Singh et al. 2001).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The Maillard reaction generates these highly reactive dicarbonyls, also referred to as 𝛼-oxoaldehydes, which in addition to methylglyoxal include glyoxal and 3deoxyglucosone. [17]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Role of the Maillard Reaction in Aging of Tissue Proteins
Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18714 · Cited by 366
Giardino, I., Edelstein, D., & Brownlee, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117296 · Cited by 364
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Research works printed but not linked: 2
- Kennedy L (1992) Glycation of immunoglobulins and serum proteins. In: Alberti KGMM, de Fronzo RA, Keen H, Zimmet P (eds) International Textbook of Dia- betes Mellitus, 2nd edn. John Wiley, Chichester pp 985±1007
- Neumann A, Schinzel R, Palm D, Riederer P, Munch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation end-product induced NF-kappaB acti- vation and cytokine expression. FEBS Letters 453: 283±287
Cited by
Items 301–400 of 1,005
Heterogeneity Affecting Outcome From Acute Stroke Therapy: Making Reperfusion Worse
Kent, T. A., Soukup, V. M., & Fabian, R. H. (2001) · Stroke · doi:10.1161/hs1001.096588 · Cited by 103
A Comprehensive Review of Erectile Dysfunction in Men with Diabetes
Kamenov, Z. A. (2014) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0034-1394383 · Cited by 137
“AGEs bond covalently to the vascular collagen leading to thickening of the vascular wall, deceased elasticity, endothelial dysfunction and atherosclerosis (Bucala et al., 1991; Singh et al., 2001a).”
BackgroundNew Treatment Options for Erectile Dysfunction in Patients with Diabetes Mellitus
Basu, A., & Ryder, R. E. J. (2004) · Drugs · doi:10.2165/00003495-200464230-00004 · Cited by 121
The Maillard reaction and pet food processing: effects on nutritive value and pet health
van Rooijen, C., Bosch, G., van der Poel, A. F. B., Wierenga, P. A., Alexander, L. G., & Hendriks, W. H. (2013) · Nutrition Research Reviews · doi:10.1017/s0954422413000103 · Cited by 123
“osteoarthritis and neurodegenerative diseases such as Alzheimer’s disease in humans((17,79,82)).”
Methylglyoxal – An emerging biomarker for diabetes mellitus diagnosis and its detection methods
Ramachandra, B. L., Vedantham, S., Krishnan, U. M., & Rayappan, J. B. B. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.03.010 · Cited by 103
Afridi, R., Kim, J.-H., Rahman, M. H., & Suk, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00020 · Cited by 98
Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
Oshitari, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032927 · Cited by 113
“Amadori compounds are relatively stable and can be precursors of AGEs [15].”
BackgroundThe role of mass spectrometry in the study of non‐enzymatic protein glycation in diabetes: An update
Lapolla, A., Fedele, D., Seraglia, R., & Traldi, P. (2006) · Mass Spectrometry Reviews · doi:10.1002/mas.20090 · Cited by 102
Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat, M., Muthenna, P., Suryanarayana, P., Petrash, J. M., & Reddy, G. B. (2008) · PubMed · Cited by 102
Ottum, M. S., & Mistry, A. M. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-3 · Cited by 98
Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus
Zhao, J.-B. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i18.2846 · Cited by 96
“Advanced glycation end products (AGEs) produced during the development of DM likely relate to the morphological changes and biomechanical remodeling of the GI tract in DM. AGEs are generated by the sequential non-enzymatic glycation of protein amino groups and by oxidation reaction [149] .”
BackgroundDysfunction of retinal neurons and glia during diabetes
Fletcher, E. L., Phipps, J. A., & Wilkinson‐Berka, J. L. (2005) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2005.tb06686.x · Cited by 116
Involvement of maillard reactions in Alzheimer disease
Reddy, V. P., Obrenovich, M. E., Atwood, C., Perry, G. L., & Smith, M. A. (2002) · Neurotoxicity Research · doi:10.1080/1029840290007321 · Cited by 112
“The administration of aminoguanidine in diabetic patients results in the amelioration of diabetic complications, but its clinical use has been abandoned due to adverse effects in some patients in the Phase III clinical trials (Singh et al., 2001).”
BackgroundKokil, G. R., Veedu, R. N., Ramm, G. A., Prins, J. B., & Parekh, H. S. (2015) · Chemical Reviews · doi:10.1021/cr5002832 · Cited by 111
Li, X., Xiao, J., Zha, X., Pan, L., Asghar, M., & Luo, J. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.02.029 · Cited by 100
Meeprom, A., Sompong, W., Chan, C. B., & Adisakwattana, S. (2013) · Molecules · doi:10.3390/molecules18066439 · Cited by 100
“generated either from oxidative breakdown of Amodori product [31] or polyol pathway mediated by α-oxoaldehydes such as glyoxal, methylglyoxal, and 3-deoxyglucosone [32], was also inhibited by IFA both in fructose- and glucose-induced glycation.”
BackgroundHow Can Diet Affect the Accumulation of Advanced Glycation End-Products in the Human Body?
Guilbaud, A., Niquet-Leridon, C., Boulanger, E., & Tessier, F. (2016) · Foods · doi:10.3390/foods5040084 · Cited by 95
“Their concentration increases with age, but is also closely related to renal failure and diabetes [2].”
BackgroundBlocking AGE-RAGE Signaling Improved Functional Disorders of Macrophages in Diabetic Wound
Wang, Q., Zhu, G., Cao, X., Dong, J., Song, F., & Niu, Y. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1428537 · Cited by 106
Advanced glycation end products and diabetic retinopathy
Milne, R. W., & Brownstein, S. (2011) · Amino Acids · doi:10.1007/s00726-011-1071-3 · Cited by 106
“AGEs can arise from modification of protein amine groups by reducing sugars and by reactive dicarbonyls, such as glyoxal, methylglyoxal (MG) and 3-deoxyglucosone (Singh et al. 2001; Ulrich and Cerami 2001).”
BackgroundThe modification of α-synuclein by dicarbonyl compounds inhibits its fibril-forming process
Lee, D., Park, C. W., Paik, S. R., & Choi, K. Y. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.016 · Cited by 101
Cytoprotective effects of phenolic acids on methylglyoxal‐induced apoptosis in Neuro‐2A cells
Huang, S., Chuang, H.-C., Wu, C., & Yen, G. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700360 · Cited by 99
“Methylglyoxal is one of a series of glycation intermediates (dicarbonyls), which includes such reactive intermediates as glucosone, 3-deoxyglucosone and glyoxal that have been identified during Amadori rearrangement in the Maillard reaction [1].”
BackgroundOkazaki, K., Yamaguchi, T., Tanaka, K.-I., Notsu, M., Ogawa, N., Yano, S., & Sugimoto, T. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9641-2 · Cited by 98
“In prolonged hyperglycemia seen in advanced diabetes mellitus, glucose reacts with proteins to form unstable Schiff bases, which undergo further modification to form Amadori products and then advanced glycation end products (AGEs) [12, 13].”
Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
Burska, A. N., Hunt, L., Boissinot, M., Strollo, R., Ryan, B. J., Vital, E., Nissim, A., Winyard, P. G., Emery, P., & Ponchel, F. (2014) · Mediators of Inflammation · doi:10.1155/2014/492873 · Cited by 92
Chemoselective Reactions for the Synthesis of Glycoconjugates from Unprotected Carbohydrates
Villadsen, K., Martos‐Maldonado, M. C., Jensen, K. J., & Thygesen, M. B. (2017) · ChemBioChem · doi:10.1002/cbic.201600582 · Cited by 99
Glycation changes molecular organization and charge distribution in type I collagen fibrils
Bansode, S. B., Bashtanova, U. B., Li, R., Clark, J. P., Müller, K. H., Puszkarska, A. M., Goldberga, I., Chetwood, H. H., Reid, D. G., Colwell, L. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60250-9 · Cited by 101
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 109
Wohlgemuth, R. P., Brashear, S. E., & Smith, L. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2023 · Cited by 110
Post-translational modifications and their implications in cancer
Dutta, H., & Jain, N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1240115 · Cited by 107
“Previous animal studies have extensively reported that GALNT class of enzymes (GALNT1-GALNT20) act as prognostic markers for different cancers, or have been linked to alterations in cellular characteristics including cell proliferation, migration, invasion and metastasis in experimental models (6).”
Inhibition of acrylamide formation by vitamins in model reactions and fried potato strips
Zeng, X., Cheng, K., Jiang, Y., Lin, Z., Shi, J.-J., Ou, S., Chen, F., & Wang, M. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2009.01.093 · Cited by 98
‘Lipoproteins, glycoxidation and diabetic angiopathy’
Jenkins, A. J., Best, J. D., Klein, R. L., & Lyons, T. J. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.491 · Cited by 96
Non Transferrin Bound Iron: Nature, Manifestations and Analytical Approaches for Estimation
Patel, M., & Ramavataram, D. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0250-7 · Cited by 104
Tikellis, C., Pickering, R. J., Tsorotes, D., Huet, O., Cooper, M. E., Jandeleit-Dahm, K., & Thomas, M. C. (2014) · Diabetes · doi:10.2337/db13-0932 · Cited by 97
“Certainly, posttranslational modification of amino, guanidino, and thiol functional groups on vulnerable proteins, lipids, and DNA targets has the potential to alter their structure, stability, and/or function (18,19).”
BackgroundAsthana, S., Mallick, B., Alexandrescu, A. T., & Jha, S. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.020 · Cited by 104
Chayaratanasin, P., Barbieri, M. A., Suanpairintr, N., & Adisakwattana, S. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0546-2 · Cited by 117
“During the propagation reaction, the Amadori products react with the amino acids to form irreversible AGEs, including fluorescent and crosslinking AGEs (such as pentosidine and imidazolones) and non-fluorescent and non-crosslinking AGEs (such as N-CML) [3-5].”
Gugliucci, A., & Menini, T. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00166-8 · Cited by 103
“Glycation is a key molecular basis of diabetic complications due to hyperglycemia [38].”
BackgroundKoo, J.-R., & Vaziri, N. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00728.x · Cited by 96
Rare mono- and disaccharides as healthy alternative for traditional sugars and sweeteners?
van Laar, A., Grootaert, C., & Camp, J. V. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1743966 · Cited by 103
Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats.
Saraswat, M., Suryanarayana, P., Reddy, P. Y., Patil, M. A., Balakrishna, N., & Reddy, G. B. (2010) · PubMed Central · Cited by 96
Mildner–Szkudlarz, S., Siger, A., Szwengiel, A., & Bajerska, J. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.09.036 · Cited by 100
Scott, S., Loera, S., Tessler, C., Chu, P., Weiss, L. M., Hardy, J. W., Rahbar, S., & Figarola, J. L. (2003) · Diabetologia · doi:10.1007/s00125-003-1162-0 · Cited by 105
“Advanced glycation/lipoxidation endproducts (AGE/ ALE) are a complex, heterogeneous, sugar/lipid derived irreverible protein modifications that have been implicated in the pathogenesis of diabetic complications, atherosclerosis, Alzheimer’s disease and in the process of normal aging [1, 2, 3, 4, 5].”
Zhang, X., Qi, J., Li, K., Yin, S., Wang, J., Jian-hua, Z., & Yang, X. (2012) · Food Research International · doi:10.1016/j.foodres.2012.09.001 · Cited by 96
Zizzi, A., Tirabassi, G., Aspriello, S. D., Piemontese, M., Rubini, C., & Lucarini, G. (2012) · Journal of Periodontal Research · doi:10.1111/jre.12007 · Cited by 107
“The rate of turnover of proteins for glycoxidation, the degree of hyperglycemia and the extent of oxidant stress in the environment are considered key factors in the formation of AGEs (11), and both intracellular and extracellular proteins may be glycated and oxidized.”
BackgroundEnvironmental pollution and the risk of developing metabolic disorders: obesity and diabetes
Khalil, W. J., Akeblersane, M., Khan, A. S., Moin, A. S. M., & Butler, A. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108870 · Cited by 95
“Common AGEs are pentosidine and N-[carboxymethyl]-lysine (CML), caused by the increased presence of glucose [64].”
BackgroundEroglu, E. I., Ayaz, A., & Büyüktuncer, Z. (2019) · Nutrition Research Reviews · doi:10.1017/s0954422419000209 · Cited by 102
“effect) and fluorescence formation(4).”
Zhu, Z., Huang, M., Cheng, Y., Khan, I. A., & Huang, J. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.01.021 · Cited by 96
Non-enzymatic covalent modifications: a new link between metabolism and epigenetics
Zheng, Q., Maksimovic, I., Upad, A., & David, Y. (2020) · Protein & Cell · doi:10.1007/s13238-020-00722-w · Cited by 100
Pertyńska−Marczewska, M., Kiriakidis, S., Wait, R., Beech, J. T., Feldmann, M., & Paleolog, E. M. (2004) · Cytokine · doi:10.1016/j.cyto.2004.06.006 · Cited by 101
Bos, D. C., de Ranitz-Greven, W. L., & de Valk, H. W. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0034 · Cited by 93
“First, AGEs can form cross-links with proteins that affect the threedimensional structure and thereby the functions of these proteins.(6) Second, AGEs can cause harmful effects by the activation of receptors for AGEs.”
The link between advanced glycation end products and apoptosis in delayed wound healing
Shaikh‐Kader, A., Houreld, N. N., Rajendran, N. K., & Abrahamse, H. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3424 · Cited by 101
Wu, C., Chen, J.-S., Lu, K., Chen, C., Lin, S., Chu, P., Sytwu, H., & Lin, Y. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.036 · Cited by 100
Tanimoto, M., Gohda, T., Kaneko, S., Hagiwara, S., Murakoshi, M., Aoki, T., Yamada, K. H., Ito, T., Matsumoto, M., Horikoshi, S., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2006.08.026 · Cited by 94
Goldberg, H. J., Whiteside, C. I., & Fantus, I. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112331200 · Cited by 93
Atypical Femoral Fractures: What Do We Know About Them?
Unnanuntana, A., Saleh, A., Mensah, K. A., Kleimeyer, J. P., & Lane, J. M. (2013) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.l.00568 · Cited by 98
Opportunities for organoids as new models of aging
Hu, J. L., Todhunter, M. E., LaBarge, M. A., & Gartner, Z. J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709054 · Cited by 87
Advanced Glycation End Product Precursors Impair Epidermal Growth Factor Receptor Signaling
Portero-Otín, M., Pamplona, R., Bellmunt, M. J., Ruiz, M. C., Prat, J., Salvayre, R., & Nègre-Salvayre, A. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1535 · Cited by 92
“Finally, the protective effect of the dicarbonyl scavenger aminoguanidine, which prevents GO/MGO–induced EGFR signaling impairment, is also consistent with the effectiveness of aminoguanidine to slow the progression of a wide range of diabetic complications (41,42).”
ResultThe Role of Mitochondria in Diabetic Kidney Disease
Hallan, S. I., & Sharma, K. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0748-0 · Cited by 98
Linking perceived control, physical activity, and biological health to memory change.
Infurna, F. J., & Gerstorf, D. (2013) · Psychology and Aging · doi:10.1037/a0033327 · Cited by 90
Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits
Zawada, A. E., Machowiak, A., Rychter, A. M., Ratajczak, A. E., Szymczak‐Tomczak, A., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2022) · Nutrients · doi:10.3390/nu14193982 · Cited by 101
“Glycation is a non-enzymatic process; thus, its speed is expressed by the serum level of glucose (fructose, galactose) [20,21].”
BackgroundKranstuber, A. L., del Rio, C., Biesiadecki, B. J., Hamlin, R. L., Ottobre, J., Gyorke, S., & Lacombe, V. A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00292 · Cited by 94
Jiao, L., Stolzenberg‐Solomon, R. Z., Zimmerman, T. P., Duan, Z., Chen, L., Kahle, L., Risch, A., Subar, A. F., Cross, A. J., Hollenbeck, A. R., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.098061 · Cited by 102
“CML is one of the chemically and biologically well-characterized AGEs (11).”
BackgroundAlves, M., Calegari, V. C., Cunha, D. A., Saad, M. J. A., Velloso, L. A., & Rocha, E. M. (2005) · Diabetologia · doi:10.1007/s00125-005-0010-9 · Cited by 98
“Various recent reports have described increased AGE accumulation, AGER expression and NFKB1 activation in the organs of diabetic animals, and have postulated the pathophysiological relevance of these cellular events in diabetic complications such as diabetic retinopathy [10, 13].”
BackgroundPlasma α-Oxoaldehyde Levels in Diabetic and Nondiabetic Chronic Kidney Disease Patients
Nakayama, K., Nakayama, M., Iwabuchi, M., Terawaki, H., Sato, T., Kohno, M., & Ito, S. (2008) · American Journal of Nephrology · doi:10.1159/000139653 · Cited by 87
“On the other hand, a-oxoaldehydes such as glyoxal (GO), methylglyoxal (MG), and 3-deoxyglucosone (3DG) are spontaneously formed as metabolites of carbohydrates, lipids and amino acids, which are present throughout the human body [ , , , ,”
BackgroundSusceptibility of LDL and its subfractions to glycation
Soran, H., & Durrington, P. N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328348a43f · Cited by 89
Adamiec-Mroczek, J., Oficjalska−Młyńczak, J., & Misiuk‐Hojło, M. (2009) · Cytokine · doi:10.1016/j.cyto.2009.11.004 · Cited by 91
Kim, J., Kim, C., Sohn, E., Jeong, I.-H., Kim, H., & Kim, J. S. (2010) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1573-9 · Cited by 93
“It was recently reported that increased AGEs accumulation and NF-κB activation by AGE/RAGE interaction contribute to the development of diabetic ocular complications, such as diabetic retinopathy and lacrimal gland dysfunction [14, 25–27].”
BackgroundHuang, S., Wu, C., & Yen, G. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600075 · Cited by 90
Biomarkers of oxidative/nitrosative stress: an approach to disease prevention.
Ogino, K., & Wang, D.-H. (2007) · PubMed · doi:10.18926/amo/32871 · Cited by 107
Tan, K. C. B., Chow, W.-S., Tso, A. W. K., Xu, A., Tse, H., Hoo, R. L. C., Betteridge, D. J., & Lam, K. S. L. (2007) · Diabetologia · doi:10.1007/s00125-007-0759-0 · Cited by 91
“Hyperglycaemia leads to the increased formation and accumulation of AGE, the binding of which to their cellular receptors plays an important role in the pathogenesis of diabetic vascular complications [1, 2].”
BackgroundMori, H., Kuroda, A., Yoshida, S., Yasuda, T., Umayahara, Y., Shimizu, S., Ryomoto, K., Yoshiuchi, K., Yamamoto, T., Matsuoka, T., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13436 · Cited by 90
Lekshmi, P. C., Arimboor, R., Nisha, V. M., Menon, A. N., & Raghu, K. G. (2013) · Journal of Food Science and Technology · doi:10.1007/s13197-013-0953-7 · Cited by 90
“Agents those inhibit or retard AGEs formation are believed to have therapeutic potential in diabetic patients (Singh et al. 2001).”
BackgroundInfluentialTam, X., Shiu, S. W. M., Leng, L., Bucala, R., Betteridge, D. J., & Tan, K. C. B. (2010) · Clinical Science · doi:10.1042/cs20100256 · Cited by 90
Zhao, X., Xu, F., Qi, B., Hao, S., Li, Y., Li, Y., Zou, L., Lu, C., Xu, G., & Hou, L. (2014) · Journal of Proteome Research · doi:10.1021/pr401130w · Cited by 89
Verbeke, P. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00752-3 · Cited by 90
“AP, as well as highly reactive -oxoaldehydes produced from other metabolic pathways, can undergo a complex series of reactions to form the socalled advanced glycation end products (AGE) [7,9,10].”
BackgroundA review of recent advances and current hypotheses on the pathogenesis of acute laminitis
Katz, L. M., & Bailey, S. R. (2012) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.2012.00664.x · Cited by 110
“Advanced glycation end-products are formed as a result of nonenzymatic reactions between carbohydrates and proteins [118] and accumulate in tissues in response to situations such as inflammation and hyperglycaemia, contributing to tissue damage and dysfunction as well as having pro-inflammatory effects [119,120].”
BackgroundThomas, M. C., Woodward, M., Neal, B., Li, Q., Pickering, R., Marre, M., Williams, B., Perkovic, V., Cooper, M. E., Zoungas, S., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0925 · Cited by 87
“Posttranslational modification of functional groups on vulnerable proteins, lipids, and DNA targets has the potential to alter their structure, stability, and/or function (6,7).”
BackgroundKarimi, J., Goodarzi, M. T., Tavilani, H., Khodadadi, I., & Amiri, I. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.09.024 · Cited by 96
“[11] Singh R, Barden A, Mori T, Beilin L.”
BackgroundKim, J., Jeong, I.-H., Kim, C., Lee, Y. M., Kim, J. S., & Kim, J. S. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0319-5 · Cited by 90
Ahmed, A., Shamsi, A., Khan, M. S., Husain, F. M., & Bano, B. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.02.137 · Cited by 89
Biomarkers of oxidative stress in the fetus and in the newborn
Perrone, S., Laschi, E., & Buonocore, G. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.03.034 · Cited by 98
Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences
Sergi, D., Renaud, J., Simola, N., & Martinoli, M.-G. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00302 · Cited by 86
“As described for the induction of oxidative stress, the activation of the RAGE by AGEs triggers deleterious inflammatory pathways (Singh et al., 2001; Jakus and Rietbrock, 2004).”
BackgroundBrodeur, M. R., Bouvet, C., Bouchard, S., Moreau, S., Leblond, J., deBlois, D., & Moreau, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085922 · Cited by 85
“producing the Maillard reaction, rearranged in a more stable Amadori product [11].”
BackgroundAttenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats
Wang, X., Jia, X., Chang, T., Desai, K., & Wu, L. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f4a13c · Cited by 88
Piperi, C., Γούμενος, Α., Adamopoulos, C., & Papavassiliou, A. G. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.009 · Cited by 91
Salum, E., Kals, J., Kampus, P., Salum, T., Zilmer, K., Aunapuu, M., Arend, A., Eha, J., & Zilmer, M. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.008 · Cited by 103
A metabolic and functional overview of brain aging linked to neurological disorders
Baquer, N. Z., Taha, A., Kumar, P., McLean, P., Cowsik, S. M., Kale, R. K., Singh, R., & Sharma, D. (2009) · Biogerontology · doi:10.1007/s10522-009-9226-2 · Cited by 96
“In tissues affected by diabetes the amount of AGE’s are generally increased, leading to structural changes in the extracellular matrix, as well as to modifications of cell membranes and intracellular components (Brownlee 2000; Singh et al. 2001; Siddiqui et al. 2005).”
BackgroundSelf-citationDiabetes and brain aging: Epidemiologic evidence
Launer, L. J. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0069-1 · Cited by 95
How methylglyoxal kills bacteria: An ultrastructural study
Rabie, E., Serem, J. C., Oberholzer, H. M., Gaspar, A. R. M., & Bester, M. J. (2016) · Ultrastructural Pathology · doi:10.3109/01913123.2016.1154914 · Cited by 70
Advanced Glycation End-Products and Their Effects on Gut Health
Phuong-Nguyen, K., McNeill, B. A., Aston‐Mourney, K., & Rivera, L. R. (2023) · Nutrients · doi:10.3390/nu15020405 · Cited by 89
“Advanced glycation end-products (AGEs) are a group of chemically heterogeneous compounds that are formed through the Maillard reaction when reducing sugars react nonenzymatically with amino groups in proteins, nucleic acids, and lipids [1].”
BackgroundEndogenous Photosensitizers in Human Skin
Bastos, E. L., Quina, F. H., & Baptista, M. S. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00787 · Cited by 91
Linking RAGE and Nox in diabetic micro- and macrovascular complications
Koulis, C., Watson, A. M. D., Gray, S. P., & Jandeleit-Dahm, K. A. M. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.01.006 · Cited by 96
Wang, Y., Juliani, H. R., Simon, J. E., & Ho, C. (2008) · Food Chemistry · doi:10.1016/j.foodchem.2008.12.014 · Cited by 86
Kolati, S. R., Kasala, E. R., Bodduluru, L. N., Mahareddy, J. R., Uppulapu, S. K., Gogoi, R., Barua, C. C., & Lahkar, M. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.01.019 · Cited by 87
Bio-physical characterization of ribose induced glycation: A mechanistic study on DNA perturbations
Akhter, F., Khan, M. S., Shahab, U., Moinuddin, M., & Ahmad, S. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.03.036 · Cited by 86
Lubitz, I., Ricny, J., Atrakchi‐Baranes, D., Shemesh, C., Kravitz, E., Liraz‐Zaltsman, S., Maksin‐Matveev, A., Cooper, I., Leibowitz, A., Uribarri, J., et al. (2016) · Aging Cell · doi:10.1111/acel.12436 · Cited by 84
“Advanced glycation end products AGEs may accumulate in vascular tissues, thickening and stiffening vascular walls, and increasing the risk of hypertension (Singh et al., 2001; Goh & Cooper, 2008).”
BackgroundKocadağlı, T., & Gökmen, V. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf502418n · Cited by 86
Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs
Lee, E. J., Kim, J. Y., & Oh, S. H. (2016) · Scientific Reports · doi:10.1038/srep27848 · Cited by 98
Alteration of human serum albumin binding properties induced by modifications: A review
Maciążek-Jurczyk, M., Szkudlarek, A., Chudzik, M., Pożycka, J., & Sułkowska, A. (2017) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2017.05.023 · Cited by 90
Platelet‐Activation Mechanisms and Vascular Remodeling
Rubenstein, D. A., & Yin, W. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170049 · Cited by 94
Recent design strategies and applications of small molecule fluorescent probes for food detection
Zhang, P., Su, J., Zhen, H., Yu, T., Wei, L., Zheng, M., Zeng, C., & Shu, W. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216232 · Cited by 90
Papachroni, K. K., Piperi, C., Levidou, G., Korkolopoulou, P. A., Pawelczyk, L. A., Diamanti‐Kandarakis, E., & Papavassiliou, A. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00841.x · Cited by 85
“Up-regulation of AP-1 is in accord with studies that show potentiation of AP-1 in response to oxidative stress [36].”
Result
Metadata
- Authors
- Singh, R., Barden, A., Mori, T., & Beilin, L.
- Affiliations
- The University of Western Australia (AU)
- Venue
- Diabetologia
- Published
- 2001-02-05
- Volume
- 44
- Issue
- 2
- Pages
- 129-146
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1966234811
- Cited by
- 2,597
- References
- 45
- Citations by year
- 2026: 67 · 2025: 85 · 2024: 124 · 2023: 117 · 2022: 152 · 2021: 161 · 2020: 138 · 2019: 142 · 2018: 118 · 2017: 118 · 2016: 130 · 2015: 139 · 2014: 132 · 2013: 114 · 2012: 132
- FWCI
- 36.26
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-30)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- advanced glycation end products, diabetes complications, diabetic microvascular complications, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, diabetic vascular disease, carbonyl stress, aminoguanidine
- MeSH terms
- Receptor for Advanced Glycation End Products, Aging, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Neuropathies, Diabetic Retinopathy, Food, Humans, Plants, Toxic, Receptors, Immunologic, Nicotiana, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.